Signaling Pathways - MARK1 - Akt - PP2A/Nkd interaction - KDR
清除全部
- B6099 LY3023414Target: Akt|PI3K|mTOR|DNA-PKSummary: I类PI3K,mTOR和DNA-PK抑制剂
- B7700 IQ 1Target: Stem Cell Differentiation|PP2A/Nkd interactionSummary: 维持胚胎干细胞(ESC)的多能性
- B7105 10-DEBC hydrochlorideTarget: AktSummary: Akt抑制剂
- B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂
- B2180 AS-252424Target: Akt|PI3KSummary: PI3Kγ抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- A8617 CCT128930 HClTarget: AktSummary: AKT抑制剂
- A8616 A-674563Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSKSummary: Akt1 / PKA / CDK2的强效选择性抑制剂
- A8499 PF-04691502Target: Akt|PI3K|mTORSummary: PI3K/mTOR (FRAP)抑制剂
- A8309 Perifosine1 Citation中文名: 哌立福新Target: AktSummary: Akt抑制剂